Subscribe to Newsletter
Business & Regulation Business Practice, Standards & Regulation

Moderna Begins New Search for Chief Financial Officer

Moderna has been in the headlines this past week – but not for vaccines.

Jorge Gomez started his role as Moderna’s Chief Financial Officer (CFO) on Monday May 9. On May 11, Moderna announced his departure – effective immediately – after Gomez’s former employer, Dentsply Sirona, announced an ongoing internal investigation into “certain matters” – including financial reporting.

The investigation reportedly relates to “the Company’s use of incentives to sell products to distributors in the third and fourth quarters of 2021 and whether those incentives were appropriately accounted for and the impact of those sales was adequately disclosed.”

Dentsply Sirona terminated CEO Don Casey back in April without revealing the reason. Gomez also resigned in April; at the time, however, it was stated that “Gomez’s decision to resign is not the result of any dispute or disagreement with the Company, the Company’s management or the Board of Directors of the Company on any matter relating to the Company’s operations, policies or practices.”

Gomez has also not been named in the investigation, although Dentsply Sirona says it is investigating both former and current members of senior management. Various news outlets claim that Gomez will receive his annual salary of US$700,000 in a severance package from Moderna (although he will not be eligible for his $500,000 signing bonus). However, it has also been reported that Moderna can claim back the severance if Gomez is fined or found to have engaged in any wrongdoing as part of the Dentsply Sirona investigation.

Moderna’s recently retired CFO, David Meline, has stepped back into the role while Moderna searches for a replacement. Meline has actually retired from Moderna before, but came out of retirement in 2020 to help the company with its COVID-19 work.

Gomez had been with Dentsply Sirona since 2019, where he was also responsible for the company’s sustainability and ESG program. Before Dentsply Sirona, he spent 13 years at Cardinal Health.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine